Skip to main content
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · XENE ISIN · CA98420N1050 LEI · 549300XV44Q9Z1MIPQ03 US Manufacturing
Filings indexed 734 across all filing types
Latest filing 2024-08-08 Earnings Release
Country CA Canada
Listing US XENE

About Xenon Pharmaceuticals Inc.

https://www.xenon-pharma.com/

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to the discovery, clinical development, and commercialization of therapeutics for neurological and psychiatric disorders. The company leverages its expertise in human genetics and a deep understanding of ion channel biology to develop medicines that modulate ion channels, targeting the central and peripheral nervous systems. Its late-stage pipeline includes azetukalner, an investigational candidate being developed for the treatment of epilepsy and depression.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 8, 2024, by Xenon Pharmaceuticals Inc. It announces the company's financial results for the three and six months ended June 30, 2024, via a press release attached as Exhibit 99.1. The text explicitly states that the information is furnished but not filed, and the press release is attached. The document does not contain the actual financial statements or detailed financial data but rather announces the results and provides a link to the press release. This matches the characteristics of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only. The document length is under 5,000 characters, consistent with a brief announcement rather than a full report. Therefore, the correct classification is Earnings Release (ER).
2024-08-08 English
Regulatory Filings 2024
Regulatory Filings
2024-07-13 English
Regulatory Filings 2024
Regulatory Filings
2024-06-12 English
4
Director's Dealing
2024-06-05 English
4
Director's Dealing
2024-06-05 English
4
Director's Dealing
2024-06-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.